Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
about
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseasesRecent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug developmentA neurobiological basis for substance abuse comorbidity in schizophreniaAspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease.Seeking brain biomarkers for preventive therapy in Huntington disease.D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics.Tetrabenazine is neuroprotective in Huntington's disease mice.Schizophrenia: D4 receptor elevation. What does it mean?Monoaminergic synapses and schizophrenia: 45 years of neuroleptics.Measurement of density and affinity for dopamine D(2) receptors by a single positron emission tomography scan with multiple injections of [(11)C]raclopride.Presynaptic regulation of dopamine transmission in schizophrenia.Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets.In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease.Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.Investigating the neurodevelopmental hypothesis of schizophrenia.Using human brain imaging studies as a guide toward animal models of schizophrenia.Rapid changes in d1 and d2 dopamine receptor binding in striatal subregions after a single dose of phencyclidine.Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleusCorticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.Presynaptic dopamine in schizophrenia.Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.The role of the human globus pallidus in Huntington's disease.Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.New perspectives on the clinical neurobiology of treatment response in schizophrenia.Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease
P2860
Q26830654-9C5FCAD0-8140-42CE-9798-DF9B4F8AFC06Q27014737-8A6956BE-BE4D-4407-8EA9-9C7B5DC9E79FQ28347063-DD7932FB-023C-433F-A0FC-8C507CBB5719Q31797771-7A7421D9-D160-4EE9-B512-D15AC332DA21Q33606063-8A2E2FFD-C9B6-4F20-8EF9-3601351E223AQ33692872-63A0AA85-DD2A-4B43-9A9F-9348634A5EFFQ33863426-3849F781-AE9D-48D2-A347-D1FDA81C13A4Q33921370-08424678-E59E-465D-B22C-9BF73C9E5206Q34013426-AB0F15B8-1D07-4887-910D-11176AAF7ACFQ34170886-B33C5396-B622-4D5D-8A98-8C5480217EB6Q34415890-F2C15FE8-13A3-42BA-8FC6-4878AD7238FAQ35049600-D5990178-445B-443E-A54E-75C5F80C4369Q35116551-FC820BBF-C2B0-42B2-9BA4-582490E8B584Q35236303-161D2948-B0DC-424B-8D83-462DB01F4403Q35839434-7A1BB97E-9020-4CA5-8A95-E7C715D40BB5Q36262192-52BD8E49-E888-4CDA-B05C-A661D22E9CE2Q36332602-65900D36-496C-440A-BD96-BE3E7DA88803Q36600553-05FE9561-414E-4743-81C5-C6AD29084E7FQ36990801-5FC69B0E-F89D-4D5D-AC96-198C9C138F0EQ37346892-C4065C42-E212-46EA-AD6C-64E683CF9955Q37349826-2C256A7C-DDA7-46D6-909C-74B2F928CC40Q37825635-278CD96F-557B-4B58-B081-0A9385957702Q38121068-44328632-2BCC-4348-81E4-A61DC2B57627Q38928744-E24DE0F4-9CB5-4021-B106-C4E6CAC41E77Q39916831-204D4325-49C2-49FA-B5FE-C624392009D1Q40448086-DA9D419C-E5A9-43D1-9114-01A1B761FC9DQ40623093-3356B7E9-B054-44ED-A4A8-4ECE363D1D49Q41271272-476164BF-99AB-4B41-B036-4D03911D3362Q43544209-993FE8A2-5839-447E-B8F0-591A644E9EACQ45305746-8F8BA4F9-7EF9-4420-A4EA-7236A31ADEA3Q48572048-9FFFC17D-1242-420B-B624-83D258DDA797Q51813520-8FAF63DC-34D3-4043-AFD1-3FEC2A4F2AE3Q52685691-D2405EFD-6F1A-4E01-BDE3-163A6A753045Q58771741-7602E45E-27D1-43DD-84FE-354765A9BFEF
P2860
Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@en
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@nl
type
label
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@en
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@nl
prefLabel
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@en
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@nl
P2093
P921
P356
P1433
P1476
Organization of dopamine D1 an ...... n's disease and schizophrenia.
@en
P2093
P304
P356
10.1002/SYN.890020511
P577
1988-01-01T00:00:00Z